Concepedia

Author

Katherine Kolbert

Memorial Sloan Kettering Cancer Center

Also Known As

K Kolbert, K S Kolbert, K. S. Kolbert, Katherine Kolbert, Katherine S Kolbert, Katherine S. Kolbert

23

Publications

1.6K

Citations

16

H-Index

25

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterCornell UniversityCenter for Molecular Medicine and ImmunologyUniversity of Göttingen
KK

About

Katherine Kolbert is an author at Memorial Sloan Kettering Cancer Center specializing in health sciences, nuclear medicine, and medical imaging.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

4

4

245

2

Engineering

2

2

69

3

Medicine

2

2

176

4

Biomedical Engineering

1

1

23

5

Pathology

1

1

46

Katherine Kolbert

×

15

Publications

1.5K

Citations

15

H-Index

YearCitations

Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.

George Sgouros, Katherine Kolbert, Arif Sheikh,

PubMed

2004

307

Resistance of [ <sup>18</sup> F]-Fluorodeoxyglucose-Avid Metastatic Thyroid Cancer Lesions to Treatment with High-Dose Radioactive Iodine

Weiping Wang, Steven M. Larson, R. Michael Tuttle,

Thyroid

2001

178

Implementation and evaluation of patient-specific three-dimensional internal dosimetry.

Katherine Kolbert, George Sgouros, Andrew M. Scott,

PubMed

1997

125

Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response.

George Sgouros, Shannon Squeri, Åse Ballangrud,

PubMed

2003

119

Overcoming the nephrotoxicity of radiometal‐labeled immunoconjugates

Thomas M. Behr, Robert M. Sharkey, George Sgouros,

Cancer

1997

108

Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.

Stig Palm, Richard M. Enmon, Cornelia Matei,

PubMed

2003

98

Prognostic Value of[ 18F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid Cancer*

Weiping Wang, Steven M. Larson, Melissa Fazzari,

The Journal of Clinical Endocrinology & Metabolism

2000

96

Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software.

Katherine Kolbert, Keith S. Pentlow, Joel R Pearson,

PubMed

2007

95

Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT.

Sadek A. Nehmeh, Yusuf E. Erdi, Hovanes Kalaigian,

PubMed

2003

91

Implementation of a Monte Carlo dosimetry method for patient‐specific internal emitter therapy

E Furhang, Chen S. Chui, Katherine Kolbert,

Medical Physics

1997

80

Page 1